XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.24.0.1

NET LOSS PER SHARE | 9 Months Ended
--- | ---
Dec. 31, 2023
Earnings Per Share [Abstract] |
NET LOSS PER SHARE | NET LOSS PER SHARE Basic and diluted net loss per share attributable to common stockholders was calculated as follows:
| Three Months Ended December 31, |  | Nine Months Ended December 31,
| 2023 |  | 2022 |  | 2023 |  | 2022
Numerator: |  |  |  |  |  |  |
Net loss attributable to common stockholders—basic and diluted | $ | (10,108) |  |  | $ | (21,270) |  |  | $ | (32,108) |  |  | $ | (47,317) |
Denominator: |  |  |  |  |  |  |
Weighted average common shares outstanding—basic and diluted | 175,540,096 |  |  | 177,672,036 |  |  | 176,611,729 |  |  | 176,546,378 |
Net loss per share attributable to common stockholders - basic and diluted | $ | (0.06) |  |  | $ | (0.12) |  |  | $ | (0.18) |  |  | $ | (0.27) |
For the three and nine months ended December 31, 2023 and 2022, the Company excluded the following potential dilutive securities, which include stock options, RSUs, warrants and convertible notes from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of shares of common stock outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same for the three and nine months ended December 31, 2023 and 2022.
|  |  | As of
|  |  | December 31,
|  |  |  |  | 2023 |  | 2022
Stock options to purchase common stock |  |  |  |  | 12,545,294 |  |  | 16,068,852
Restricted stock units |  |  |  |  | 14,248,262 |  |  | 8,615,450 |
Warrants to purchase common stock |  |  |  |  | 13,036,333 |  |  | 13,036,333 |
2025 Convertible Notes as converted to common stock |  |  |  |  | 4,083,040 |  | 8,390,774
The Company’s convertible notes outstanding for the three and nine months ended December 31, 2023 could have obligated the Company and/or its stockholders to issue shares of common stock upon the occurrence of various future events at prices and in amounts that are not determinable until the occurrence of those future events. Because the necessary conditions for the conversion of these instruments had not been satisfied during the three and nine months ended December 31, 2023, the Company excluded these instruments from the table above and the calculation of diluted net loss per share for the period. See Note 4, “Debt,” for additional details.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration